Hot penny stocks... don't get burned
   

News for Cadence Pharmaceuticals, Inc (CADX)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for Cadence Pharmaceuticals Inc.  (CADX) 
|
$ 9.91      -0.01 (-0.10%) Volume: 383.45 k 4:00 PM EDT Aug 29, 2008
After Hours:  $ 9.91 0.00 (0.00%) Volume: 1.2 k 4:04 PM EDT Aug 29, 2008
Thu, Aug 28, 2008
5:16 PM Cadence Pharmaceuticals Appoints Todd Rich, M.D. to its Board of Directors and Names Malcolm Lloyd-Smith as Senior Vice President, Regulatory Affairs and Quality Assurance - PR Newswire
Wed, Aug 27, 2008
8:00 PM Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the 2008 NewsMakers In the Biotech Industry Conference - PR Newswire
Thu, Aug 07, 2008
7:31 AM Cadence Pharmaceuticals Reports Second Quarter 2008 Financial Results and Provides Overview of Clinical Programs - PR Newswire
Mon, Aug 04, 2008
5:15 PM Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008 - PR Newswire
Wed, Jul 30, 2008
4:02 PM Cadence Pharmaceuticals Announces FDA Concurrence With Clinical Development Plan for Acetavance(TM) - PR Newswire
Mon, Jul 28, 2008
6:35 PM Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008 - PR Newswire
Tue, Jun 17, 2008
4:30 PM Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York - PR Newswire
Wed, Jun 04, 2008
4:36 PM Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York - PR Newswire
Tue, May 06, 2008
8:03 AM Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update - PR Newswire
Thu, Mar 13, 2008
7:00 PM Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston - PR Newswire
Wed, Mar 12, 2008
4:01 PM Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview - PR Newswire
Thu, Mar 06, 2008
8:49 PM Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008 - PR Newswire
Wed, Feb 20, 2008
5:01 PM Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering - PR Newswire
Fri, Feb 15, 2008
8:01 AM Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering - PR Newswire
Thu, Jan 31, 2008
8:30 PM Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York - PR Newswire
Fri, Jan 11, 2008
7:30 AM Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM) - PR Newswire
Wed, Nov 14, 2007
4:30 PM Cadence Pharmaceuticals Reports Third Quarter 2007 Financial Results and Provides Clinical Program Update - PR Newswire
Fri, Nov 09, 2007
8:00 PM Semi-Annual Changes to the NASDAQ Biotechnology Index - PrimeNewswire
9:15 AM Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2007 Financial Results - PR Newswire
Thu, Nov 08, 2007
8:58 PM Cadence Pharmaceuticals' Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference - PR Newswire
Fri, Oct 26, 2007
6:00 AM Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at BIOCOM Investor Conference 2007 - PR Newswire
Wed, Oct 03, 2007
4:30 PM Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at BIO Investor Forum - PR Newswire
Thu, Sep 20, 2007
9:01 AM Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference - PR Newswire
Thu, Sep 13, 2007
5:00 PM Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance - PR Newswire
Thu, Aug 30, 2007
6:00 AM Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule - PR Newswire
  Page 1 of 2   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for CADX stock. Download CADX report.
Research Report
Get the full report for FREE
Date:May 12, 2008
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download CADX report
  
Example preview: Research report for Cadence Pharmaceuticals, Inc (CADX) Research report for Cadence Pharmaceuticals, Inc (CADX) Research report for Cadence Pharmaceuticals, Inc (CADX) Research report for Cadence Pharmaceuticals, Inc (CADX)
   
   
   
Attention: Please help us to improve our services by answering the following poll:



Please Leave a comment to tell us how you think we can improve our services.

Your message:
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

SPKL shot up 24%


From: OTC Journal
Added: 22 Sep, 2007

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Cadence Pharmaceuticals, Inc
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.